<DOC>
	<DOCNO>NCT00351234</DOCNO>
	<brief_summary>The purpose study determine whether type I diabetics carnitine deficiency exhibit increase number hypoglycemic ( low blood sugar ) event unrecognized hypoglycemia occur continuous 72-hour glucose monitoring . If determine unrecognized hypoglycemia , oral carnitine supplementation give subject reassess number hypoglycemic event 72-hour glucose monitoring .</brief_summary>
	<brief_title>Carnitine Levels Carnitine Supplementation Type I Diabetes</brief_title>
	<detailed_description>Hypoglycemia clinical marker carnitine deficiency . Thus carnitine may compound risk hypoglycemia child insulin therapy . Currently , one limitation management diabetes hypoglycemia . The problem hypoglycemia even great significance pediatric population child small glycogen store . In study , determine group child increase frequency hypoglycemia carnitine deficiency . If correlation initial 200 child , compare two group type I diabetic child age 7 21 year . We take 20 child high carnitine level ( find previous study ) 20 child low carnitine level perform continuous glucose monitor 72-hour period . Those least one episode hypoglycemia ask undergo repeat test , 2-week period oral carnitine supplementation . Supplementation start 50 mg/kg body weight first week increase 100 mg/kg body weight second week . Laboratory study obtain baseline include Hemoglobin A1c , carnitine panel , lipid panel . These repeat prior second continuous glucose monitoring . Insulin dose change glucose monitoring session . A comparison make individual hypoglycemia , see number hypoglycemic event decrease .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Diabetes Mellitus , Type I great 2 year age 7 21 currently insulin replacement therapy Patients newly diagnose Type I diabetes Patients already take Lcarnitine Patients come clinic without glucose monitor Patients know seizure disorder include hypoglycemic seizure Patients metformin Patients compromise renal function .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Diabetes Mellitus Type I ,</keyword>
	<keyword>Hypoglycemia ,</keyword>
	<keyword>Carnitine</keyword>
</DOC>